SOLESENCE, INC. (SLSN) Form 10-K Annual Reports
SOLESENCE, INC. (SLSN) is a publicly traded company on the Nasdaq, categorized under SIC 2844 (Perfumes, Cosmetics & Other Toilet Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: SLSN
CIK: 883107
Exchange: Nasdaq
SIC 2844: Perfumes, Cosmetics & Other Toilet Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
RSM US LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerDouglas O'Connor
Audit LocationMilwaukee, Wisconsin, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-05 | 2026-09-30 | FORM 8-K | 0001171843-26-006412 | View SEC Doc Filr Page |
| 8-K | 2026-10-02 | 2026-09-29 | FORM 8-K | 0001171843-26-006367 | View SEC Doc Filr Page |
| 8-K | 2026-08-21 | 2026-08-17 | FORM 8-K | 0001171843-26-005702 | View SEC Doc Filr Page |
| 8-K | 2026-08-20 | 2026-08-19 | FORM 8-K | 0001171843-26-005676 | View SEC Doc Filr Page |
| 10-Q | 2026-08-19 | 2026-06-30 | QUARTERLY REPORT | 0001999371-26-018231 | View SEC Doc Filr Page |
| NT 10-Q | 2026-08-14 | 2026-06-30 | NT 10-Q | 0001171843-26-005544 | View SEC Doc Filr Page |
| 8-K | 2026-07-10 | 2026-07-06 | FORM 8-K | 0001171843-26-004582 | View SEC Doc Filr Page |
| 10-Q | 2026-05-12 | 2026-03-31 | QUARTERLY REPORT | 0001999371-26-010555 | View SEC Doc Filr Page |
| 8-K | 2026-05-12 | 2026-05-12 | FORM 8-K | 0001171843-26-003273 | View SEC Doc Filr Page |
| 8-K | 2026-04-29 | 2026-04-24 | FORM 8-K | 0001171843-26-002802 | View SEC Doc Filr Page |
| 10-K/A | 2026-04-23 | 2025-12-31 | AMENDMENT TO FORM 10-K | 0001999371-26-008861 | View SEC Doc Filr Page |
| 10-K | 2026-03-31 | 2025-12-31 | ANNUAL REPORT | 0001999371-26-007345 | View SEC Doc Filr Page |
| 8-K | 2026-03-31 | 2026-03-31 | FORM 8-K | 0001171843-26-002061 | View SEC Doc Filr Page |
| 4 | 2025-12-30 | 2025-12-24 | 4 | 0001193125-25-336020 | View SEC Doc Filr Page |
| 4 | 2025-12-11 | 2025-11-14 | 4 | 0001193125-25-315434 | View SEC Doc Filr Page |
| 8-K | 2025-12-03 | 2025-11-24 | FORM 8-K | 0001171843-25-007730 | View SEC Doc Filr Page |
| 8-K | 2025-12-01 | 2025-11-21 | FORM 8-K | 0001171843-25-007680 | View SEC Doc Filr Page |
| 8-K | 2025-11-13 | 2025-11-11 | FORM 8-K | 0001171843-25-007246 | View SEC Doc Filr Page |
| 10-Q | 2025-11-12 | 2025-09-30 | QUARTERLY REPORT | 0001999371-25-017415 | View SEC Doc Filr Page |
| 8-K | 2025-11-06 | 2025-11-06 | CURRENT REPORT | 0001999371-25-017120 | View SEC Doc Filr Page |
| 3 | 2025-10-06 | 2025-09-03 | 3 | 0000950130-25-000152 | View SEC Doc Filr Page |
| 8-K | 2025-09-04 | 2025-09-03 | CURRENT REPORT | 0001999371-25-012518 | View SEC Doc Filr Page |
| 8-K | 2025-08-29 | 2025-08-28 | CURRENT REPORT | 0001999371-25-012350 | View SEC Doc Filr Page |
| 10-Q | 2025-08-14 | 2025-06-30 | QUARTERLY REPORT | 0001999371-25-011366 | View SEC Doc Filr Page |
| 8-K | 2025-07-31 | 2025-07-31 | FORM 8-K | 0001171843-25-004923 | View SEC Doc Filr Page |